In Conference Call, CMD Heads Flesh Out Company's Strategy
The incoming CEO and chief operating officer of CombiMatrix Molecular Diagnostics a new subsidiary of CombiMatrix that plans to use Combi's technology in a CLIA-approved lab for manufacturing homebrew microarrays fleshed out the company's strategy in a conference call with investors last week.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
